Medication Regimen Assessment and Management of Irritability
The irritability is most likely attributable to bupropion (Wellbutrin XL 300 mg), and the first-line intervention should be to reduce the bupropion dose or discontinue it entirely, particularly given the patient is already on lamotrigine for mood stabilization.
Primary Contributors to Irritability
Bupropion as the Likely Culprit
Bupropion is well-documented to cause irritability, agitation, and hostility as neuropsychiatric side effects 1, 2. The FDA drug label explicitly warns that irritability is among the symptoms that "have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications" 2. At the current dose of 300 mg daily, the patient is at the maximum FDA-approved dose, which increases the risk of activating and anxiogenic effects 3.
Critical consideration: Bupropion's activating properties can provoke anxiety and irritability, particularly at higher doses 4. While some studies suggest bupropion may reduce anxiety in depressed patients, its stimulating dopaminergic and noradrenergic effects can also trigger irritability 3, 4.
Lamotrigine's Role
Lamotrigine 200 mg is within therapeutic range and is generally well-tolerated for mood stabilization 5. However, irritability can paradoxically emerge when patients face psychosocial stressors during recovery from mood episodes 6. The guideline emphasizes distinguishing whether irritability stems from the underlying mood disorder versus medication side effects or environmental challenges 6.
Buspirone Contribution
Buspirone 15 mg twice daily (30 mg total) is at the lower end of the therapeutic range (maximum 60 mg/day) 3. Buspirone typically takes 2-4 weeks to become effective and is generally not associated with causing irritability 3, 7. In fact, buspirone augmentation has shown efficacy in reducing anxiety symptoms when added to antidepressants 8.
Recommended Management Algorithm
Step 1: Reassess the Clinical Picture
Before making medication changes, determine:
- Timing: When did irritability begin relative to medication initiation or dose changes?
- Pattern: Is irritability constant or does it peak at certain times (suggesting medication peak effects)?
- Context: Are there concurrent psychosocial stressors that could be contributing? 6
- Comorbid symptoms: Is there associated anxiety, agitation, insomnia, or mood instability?
Step 2: Modify Bupropion
Primary recommendation:
- Reduce bupropion to 150 mg daily and monitor for 2-3 weeks, or
- Discontinue bupropion entirely if irritability is severe
Rationale: The FDA label notes that bupropion "should not be used in agitated patients" 3, and clinical experience shows that doses exceeding certain thresholds increase risk of activation and irritability 9, 10. Since the patient is already on lamotrigine for mood stabilization, the antidepressant burden from bupropion may be excessive.
Step 3: Optimize Existing Medications
If irritability persists after bupropion adjustment:
- Maintain lamotrigine 200 mg: This is an appropriate dose for mood stabilization and affective instability 5
- Consider increasing buspirone: Can titrate up to 15 mg three times daily (45-60 mg total) if anxiety is prominent 3, 7
Step 4: Consider Alternative Strategies
If irritability continues despite bupropion reduction:
- Switch to an SSRI: Agents like escitalopram or sertraline have lower risk of activation and may be better tolerated 11
- Augment with buspirone: If switching antidepressants, buspirone augmentation has demonstrated efficacy for treatment-resistant depression with 59-63% response rates 8
Critical Warnings and Monitoring
Avoid Polypharmacy Pitfalls
The guideline strongly cautions against using medications to address "all" symptoms without considering psychosocial interventions 6. Irritability related to psychosocial challenges may respond better to therapy than medication adjustments 6.
Monitor for Serious Neuropsychiatric Effects
Bupropion carries warnings for:
- Worsening depression and suicidality 1, 2
- Psychosis and mania (particularly at doses >450 mg/day, though can occur at therapeutic doses) 10, 12
- Seizure risk (dose-dependent, increases significantly above 450 mg/day) 2
Daily monitoring by caregivers is recommended during dose adjustments for emergence of agitation, hostility, or mood changes 2.
Drug Interactions
Be aware that buspirone levels can be significantly increased by CYP3A4 inhibitors (up to 20-fold with some agents), potentially causing increased side effects 7. However, at current dosing, this is unlikely to be contributing to irritability.
Practical Implementation
Immediate action:
- Reduce bupropion XL to 150 mg daily (or discontinue if irritability is severe)
- Continue lamotrigine 200 mg daily unchanged
- Continue buspirone 15 mg twice daily unchanged initially
- Schedule follow-up in 2-3 weeks to reassess
If inadequate response at 2-3 weeks:
- Consider discontinuing bupropion entirely
- Increase buspirone to 15 mg three times daily if anxiety is prominent
- Consider adding psychotherapy if not already in place 6
The key principle: Avoid the temptation to add more medications before adequately addressing the most likely culprit—bupropion's activating effects 6, 3.